Literature DB >> 8678425

Nd:YAG laser treatment for laryngeal and hypopharyngeal hemangiomas: a new technique.

S A Yellin1, A LaBruna, V K Anand.   

Abstract

The treatment of laryngeal and hypopharyngeal hemangiomas is indicated when they are symptomatic, causing dysphagia, recurrent bleeding, or airway obstruction. These tumors are found in the glottis, supraglottic larynx, and hypopharynx. Histologically, they are considered as mixed or cavernous-type hemangiomas. By utilizing a glass slide to compress the lesion, its thickness and blood flow are reduced. The tumor can then be laser-photocoagulated with less energy, with the glass slide used as a laser platform. These conditions optimize the benefits of laser ablation while minimizing the adverse heat sink effects to the surrounding healthy tissue. We present three patients with hemangiomas of the larynx and hypopharynx who were treated with this technique. The details of the technique in each case will be presented with the objective of improving the care of these unusual and challenging tumors.

Entities:  

Mesh:

Year:  1996        PMID: 8678425     DOI: 10.1177/000348949610500703

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  3 in total

1.  EUS dating with laser ablation against the caudate lobe or left liver tumors: a win-win proposition?

Authors:  Tian'an Jiang; Guo Tian; Haiwei Bao; Fen Chen; Zhuang Deng; Ju Li; Weilu Chai
Journal:  Cancer Biol Ther       Date:  2018-01-25       Impact factor: 4.742

2.  Supraglottic Hemangioma as a Rare Cause of Recurrent Hemoptysis: A New Treatment Modality with Argon Plasma Coagulation (APC).

Authors:  Akbar Sharifi; Masoud Nazemieh; Majid Moghadaszadeh
Journal:  Tanaffos       Date:  2014

3.  Unusual presentation of an adult pedunculated hemangioma of the oropharynx.

Authors:  Jérôme René Lechien; Lisa G De Marrez; Ivan Theate; Mohamad Khalife; Sven Saussez
Journal:  Clin Case Rep       Date:  2017-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.